GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

GnRHa

Company
Xiaojun Chen
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
14 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

14 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for GnRHa and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT05247268

    Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

    Not yet reported Fudan University 104 participants Est. completion 2027-09-10 1 site Stand-alone
    Other conditions: Endometrial Neoplasm Malignant Stage I
    View official trial listing →
  • Recruiting NCT NCT05316935

    GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

    Not yet reported, Not yet reported Xiaojun Chen 80 participants Est. completion 2028-03-30 2 sites Stand-alone
    Other conditions: Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance
    View official trial listing →
  • Recruiting NCT NCT05328258

    Use of GnRHa During Chemotherapy for Fertility Protection

    Not yet reported Kenny Rodriguez-Wallberg 500 participants Est. completion 2032-01-31 17 sites
    Obstructive sleep apnea Other conditions: Breast Cancer Female, Acute Leukemia, Lymphoma, Soft Tissue Sarcoma, Ewing Sarcoma
    View official trial listing →
  • Recruiting NCT NCT05567198

    Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

    National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 100 participants Est. completion 2027-05-31 1 site
    Other conditions: Systemic Lupus Erythematosus (Sle), Primary Ovarian Insufficiency (Poi)
    View official trial listing →
  • Recruiting NCT NCT05649943

    Multimodal Approach in Patients With mHSPC. Randomized Trial of APA+ADT vs APA-ADT and Local Treatment

    Not yet reported Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 566 participants Est. completion 2029-01-01 3 sites
    Other conditions: Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
    View official trial listing →
  • Recruiting NCT NCT05713578

    Efficacy and Safety of Apantamide Combined With Docetaxel and ADT vs. Apantamide Combined With ADT in Patients With High Tumor Burden mHSPC: a Multicenter and Prospective Cohort Study

    Not yet reported Qilu Hospital of Shandong University 220 participants Est. completion 2026-12-01 1 site Stand-alone
    Other conditions: Cohort Studies
    View official trial listing →
  • Recruiting NCT NCT06102863

    Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

    Not yet reported Peking University People's Hospital 38 participants Est. completion 2025-09-01 1 site
    Other conditions: Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I
    View official trial listing →
  • Recruiting NCT NCT06239376

    Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients

    Not yet reported Mỹ Đức Hospital 222 participants Est. completion 2027-05-30 1 site
    Other conditions: Adenomyosis, IVF, Frozen Embryo Transfer
    View official trial listing →
  • Recruiting NCT NCT06341621

    Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib

    Not yet reported Fudan University 1900 participants Est. completion 2029-01-01 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT06379113

    GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

    Not yet reported, Not yet reported Xiaojun Chen 29 participants Est. completion 2028-03-30 2 sites
    Other conditions: Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance, Obesity
    View official trial listing →
  • Recruiting NCT NCT06832774

    Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 192 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Prostate Cancer Metastatic Disease
    View official trial listing →
  • Recruiting NCT NCT07172685

    Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC

    Not yet reported Qilu Hospital of Shandong University 116 participants Est. completion 2027-06-30 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT07319429

    Refining Fertility-sparing Treatment in Endometrial Carcinoma Based on Molecular Classification

    Not yet reported, Not yet reported Fudan University 260 participants Est. completion 2029-12-31 2 sites Stand-alone
    Other conditions: Endometrial Cancer, Fertility
    View official trial listing →
  • Recruiting NCT NCT07696351

    Ultra-Long GnRH-a Pretreatment for FET Outcomes in Patients With Deep Infiltrating Endometriosis

    Not yet reported Li-jun Ding 120 participants Est. completion 2027-07-31 1 site
    Other conditions: Deep Infiltrating Endometriosis (DIE), Infertility
    View official trial listing →
  • Status unknown NCT NCT00334425

    The Effect of LH-Priming During Early Follicular Phase in IVF Treatment.

    Not yet reported Central Jutland Regional Hospital 150 participants 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00380406

    PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial

    Not yet reported Ottawa Hospital Research Institute 30 participants Est. completion 2010-04 4 sites
    Other conditions: Fertility Preservation, Cancer
    View official trial listing →
  • Completed NCT NCT00455689

    Understanding Experimentally Induced Hot Flushes

    Not yet reported Massachusetts General Hospital 20 participants Est. completion 2007-09-02 1 site Stand-alone
    Other conditions: Hot Flashes
    View official trial listing →
  • Status unknown NCT NCT00506480

    Assessment of Endometrial Receptivity in Recipients of Donated Oocytes

    Not yet reported Hadassah Medical Organization 100 participants Stand-alone
    Other conditions: Embryo Implantation
    View official trial listing →
  • Completed NCT NCT00522743

    Growth and Metabolic Response to GH and GnRHa Treatment Versus GH Alone in Boys Born SGA.

    Not yet reported Rabin Medical Center 17 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: SGA and Growth
    View official trial listing →
  • Completed NCT NCT00627406

    Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles

    Not yet reported Regionshospitalet Viborg, Skive 384 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: OHSS (Ovarian Hyperstimulation)
    View official trial listing →
  • Completed NCT NCT00635817

    A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

    Not yet reported Abbott 84 participants Est. completion 2010-06 25 sites
    Other conditions: Puberty, Precocious
    View official trial listing →
  • Status unknown NCT NCT00654524

    Randomized Study of Gonadotropin-releasing-hormone Agonist (GnRH-a) or Expectant Management for Endometriosis

    Not yet reported Zhejiang University 60 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT00660010

    Study of Lupron Depot In The Treatment of Central Precocious Puberty

    Not yet reported Abbott 55 participants Est. completion 2009-04 9 sites
    Other conditions: Puberty, Precocious
    View official trial listing →
  • Completed NCT NCT00667446

    Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty

    Not yet reported AbbVie (prior sponsor, Abbott) 72 participants Est. completion 2013-01 20 sites
    Other conditions: Precocious, Leuprolide Acetate, Luteinizing Hormone (LH), Gonadotrophin-releasing Hormone Agonist (GnRHa), Tanner Staging, Depot Formulation, Suppression of LH, Central Precocious Puberty (CPP), Gonadotrophin-releasing Hormone (GnRH), Lupron, GnRH Analog, Pediatrics Central Precocious Puberty
    View official trial listing →
  • Withdrawn NCT NCT00804960

    Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles?

    Not yet reported Center for Human Reproduction Est. completion 2010-04 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT00848185

    Differential Regulation of VEGF, Cadherin, Angiopietin 2 by Trigger Oocyte Maturation With GnRHa vs hCG in Donors

    IVI Madrid 96 participants Est. completion 2009-03
    Other conditions: Vascular Endothelial Growth Factor Overexpression
    View official trial listing →
  • Status unknown NCT NCT00894608

    Letrozole Combined With Gonadotropins (Gn) for Ovarian Stimulation Undergoing in Vitro Fertilization/Intracytoplasmic Sperm Injection (IVF/ICSI) in Patients With Polycystic Ovary Syndrome (PCOS)

    Not yet reported Yunyang Medical College 90 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Polycystic Ovarian Syndrome
    View official trial listing →
  • Completed NCT NCT01160315

    Efficiency of Gonadotropin-releasing Hormone (GnRH) Agonist in Preventing Chemotherapy Induced Ovarian Failure

    Not yet reported, Not yet reported Erasme University Hospital 118 participants Est. completion 2015-10 15 sites Stand-alone
    Other conditions: Fertility Preservation, Alkylating Agents, Lymphoma
    View official trial listing →
  • Completed NCT NCT01504139

    The Luteal Phase After GnRHa Trigger - a Proof of Concept Study

    Not yet reported Regionshospitalet Viborg, Skive 93 participants Est. completion 2014-08 1 site
    Other conditions: Progesterone Levels, Infertility
    View official trial listing →
  • Completed NCT NCT01581359

    The Effect of Pre-treatment With GnRH Analogues Prior in Vitro Fertilization in Patients With Endometriosis

    Not yet reported Instituto de Investigacion Sanitaria La Fe 200 participants Est. completion 2015-05 1 site
    Other conditions: Endometriosis, Infertility
    View official trial listing →
  • Terminated NCT NCT01606709

    Gene Expression Profile After Gonadotropin Releasing Hormone (GnRH) Agonist Trigger of Oocyte Maturation

    Not yet reported UConn Health 7 participants Est. completion 2014-12 1 site
    Other conditions: Endometrial Receptivity, Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Terminated NCT NCT01614067

    Delayed Start to Ovarian Stimulation

    Not yet reported University of California, San Francisco 30 participants Est. completion 2014-09 1 site
    Other conditions: Diminished Ovarian Reserve, Infertility, In Vitro Fertilization
    View official trial listing →
  • Status unknown NCT NCT01622361

    Premenopausal Patient With Hormone Responsive, HER2 Negative, Lymph Node Positive Breast Cancer

    Not yet reported Asan Medical Center 290 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01634724

    GnRH Agonist (GnRHa) Withdrawal at Late Stage of Long Protocol and the Incidence of Ovarian Hyper-stimulation

    Not yet reported Nanjing University 96 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Infertile High-risk Patients With Polycystic Ovaries
    View official trial listing →
  • Completed NCT NCT01712893

    Simultaneous Versus Sequential Use of Adjuvant Chemotherapy and GnRHa in Treating ER+,Premenopausal Breast Cancer

    Not yet reported Fudan University 216 participants Est. completion 2017-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01815138

    Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

    Not yet reported UConn Health 89 participants Est. completion 2016-10 1 site Stand-alone
    Other conditions: Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Completed NCT NCT01873378

    GnRH Agonist Pretreatment in Hysteroscopic Myomectomy

    Not yet reported Azienda Ospedaliera S. Maria della Misericordia 84 participants Est. completion 2015-08 1 site
    Other conditions: Uterine Myoma
    View official trial listing →
  • Completed NCT NCT01942369

    A Study to Describe the Efficacy of Diphereline Following Conservative Surgery in Deep Infiltrating Endometriosis (DIE) Patients Over a Period of 24 Months

    Ipsen 402 participants Est. completion 2018-07-13 18 sites
    Other conditions: Deep Infiltrating Endometriosis (DIE)
    View official trial listing →
  • Completed NCT NCT01943812

    Substituted Frozen Embryo Transfer Cycles With GnRH-agonist Supplementation

    Not yet reported Peter Humaidan 287 participants Est. completion 2020-04 2 sites Stand-alone
    Other conditions: Pregnancy Loss, Frozen Embryo Transfer
    View official trial listing →
  • Withdrawn NCT NCT01979341

    The Effect of a Dual Trigger on Intracytoplasmic Sperm Injection (ICSI) Reproductive Outcomes

    Not yet reported Antalya IVF Est. completion 2016-09 1 site
    Other conditions: Pregnancy, Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Completed NCT NCT01980680

    The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients

    Not yet reported Peter Humaidan 50 participants Est. completion 2020-05 1 site
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT02022241

    Repeated Injection of GnRH Agonist to Reduce Ovarian Hyperstimulation Syndrome

    Not yet reported Chenshiling 80 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Infertility and at High Risk of OHSS
    View official trial listing →
  • Completed NCT NCT02053779

    GnRH Agonist Trigger and Modified Luteal Phase Support, Adding a Bolus of GnRHa at the Time of Implantation - a RCT

    Not yet reported Centre Hospitalier Universitaire Ibn Rochd 328 participants Est. completion 2017-03 1 site
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02086279

    AMH Levels Change During Treatment With GnRh Agonist

    Not yet reported University Magna Graecia 67 participants Est. completion 2014-11 1 site
    Other conditions: Uterine Fibroids, Endometriosis, Endometriosis of Uterus, Pelvic Pain
    View official trial listing →
  • Completed NCT NCT02158845

    Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis

    Not yet reported University of Sao Paulo 44 participants Est. completion 2012-09 1 site
    Other conditions: Endometriosis
    View official trial listing →
  • Completed NCT NCT02208986

    GnRHa Trigger in Asian Oocyte Donors- a Dose Finding Study

    Not yet reported Vietnam National University 165 participants Est. completion 2015-03 1 site
    Other conditions: Normal Oocyte Donors
    View official trial listing →
  • Active, not recruiting NCT NCT02221999

    Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

    Not yet reported, Not yet reported RenJi Hospital 250 participants Est. completion 2029-01 12 sites Stand-alone
    Other conditions: Tubular Breast Cancer, Mucinous Breast Cancer, Invasive Ductal Breast Cancer, Inflammatory Breast Cancer
    View official trial listing →
  • Completed NCT NCT02244151

    Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval

    Not yet reported Instituto de Investigacion Sanitaria La Fe 130 participants Est. completion 2018-02-02 1 site Stand-alone
    Other conditions: Female Urogenital Diseases
    View official trial listing →
  • Status unknown NCT NCT02288130

    Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy

    Not yet reported Amsterdam UMC, location VUmc 100 participants Est. completion 2017-11 9 sites
    Other conditions: Fibroids
    View official trial listing →
  • Status unknown NCT NCT02312076

    GnRHa for Luteal Phase Support in Long GnRHa Protocol Cycles

    Not yet reported Mansoura University 200 participants Est. completion 2024-12-31 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT02312089

    GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles

    Not yet reported Mansoura University 200 participants Est. completion 2024-12-31 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT02330770

    Dual Trigger Versus GnRHa Trigger Combined With Luteal HCG Administration

    Not yet reported Mansoura University 225 participants Est. completion 2024-12-31 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT02393482

    Psychological Impact of Amenorrhea in Women With Endometriosis

    Not yet reported University of Cagliari 50 participants Est. completion 2022-06 1 site
    Other conditions: Amenorrhea, Endometriosis, Quality of Life
    View official trial listing →
  • Active, not recruiting NCT NCT02430103

    Study of Preservation of Ovarian Reserve During Chemotherapy for Young Breast Cancer Patients

    Peking University People's Hospital 349 participants Est. completion 2024-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02431689

    Delayed Embryo Transfer in Poor Responders

    Not yet reported Cairo University 400 participants Est. completion 2018-05 3 sites
    Other conditions: Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT02489318

    A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC

    Not yet reported Aragon Pharmaceuticals, Inc. 1052 participants Est. completion 2027-12-31 220 sites Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02518191

    Effects of GnRHa on Ovarian Function Against Chemotherapy-induced-gonadotoxicity

    Not yet reported Xiangyun Zong 345 participants Est. completion 2021-01-12 2 sites Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02544191

    GnRHa Combined With hCG and hMG for Treatment of Patients With Non-obstructive Azoospermia

    Not yet reported Jinling Hospital, China 30 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Azoospermia
    View official trial listing →
  • Status unknown NCT NCT02655146

    the Effects of GnRHa Add up to Routine Luteal Phase Support on Frozen Embryo Implantation in Frozen Embryo Transfer .

    Not yet reported Chong Qing Reproducive and Genetic Institute 700 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT02661789

    Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression

    Not yet reported Gitte Moos Knudsen 63 participants Est. completion 2012-12 1 site
    Other conditions: Postpartum Depression, Major Depressive Disorder, Postpartum Psychosis, Menopause, Neurodegeneration, Schizophrenia
    View official trial listing →
  • Terminated NCT NCT02677311

    GnRHA Therapy and Ovarian Preservation in Pediatric Cancer Patient

    Not yet reported University of Kentucky 2 participants Est. completion 2017-05
    Other conditions: Cancer, Chemoradiation
    View official trial listing →
  • Status unknown NCT NCT02715336

    Efficacy and Safety of Medication Used to Stimulate Ovulation

    Not yet reported Create Fertility Center 666 participants Est. completion 2021-09 1 site Stand-alone
    Other conditions: IVF Cycle, Ovarian Stimulation, Egg Retrieval, Pregnancy, Miscarriages, Ovarian Hyperstimulation
    View official trial listing →
  • Completed NCT NCT02736032

    Cryopreserved-thawed Embryo Transfer With or Without Gonadotropin Releasing Hormone Agonist

    Not yet reported Cairo University 310 participants Est. completion 2018-05 3 sites
    Other conditions: Infertility
    View official trial listing →
  • Status unknown NCT NCT02790112

    Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious Puberty

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 418 participants Est. completion 2018-10 1 site
    Other conditions: Puberty, Precocious, Adiposity
    View official trial listing →
  • Status unknown NCT NCT02856048

    Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer

    Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris 11 participants Est. completion 2021-02 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Cancer, Toxicity Due to Chemotherapy, Sarcoma, Lymphoma, Ewing Sarcoma
    View official trial listing →
  • Status unknown NCT NCT02908438

    Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer Cycles

    Not yet reported Northwest Women's and Children's Hospital, Xi'an, Shaanxi 400 participants Stand-alone
    Other conditions: GnRHa;LPS
    View official trial listing →
  • Completed NCT NCT02920515

    Study of Comprehensive Diagnosis and Treatment for Children Precocious Puberty

    Not yet reported Ruijin Hospital 740 participants Est. completion 2015-08 Stand-alone
    Other conditions: Central Precocious Puberty
    View official trial listing →
  • Status unknown NCT NCT02932761

    Comparison of the Therapeutic Effects of VR and VR + GnRHa in the Treatment of Cesarean Scar Diverticula

    Not yet reported Xipeng Wang 220 participants Est. completion 2018-07 1 site Stand-alone
    Other conditions: Cesarean Scar Diverticula
    View official trial listing →
  • Status unknown NCT NCT02940535

    Low Dose GnRHa Early Luteal Phase Down Regulation Versus GnRHa Ultra-short Protocol for Poor Ovarian Response

    Not yet reported Navy General Hospital, Beijing 200 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Subfertility, Female, Ovulation Disorder
    View official trial listing →
  • Completed NCT NCT02993926

    A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese Participants

    Takeda 108 participants Est. completion 2018-09-30 6 sites
    Other conditions: Central Precocious Puberty
    View official trial listing →
  • Completed NCT NCT03039049

    GNRH Agonist Trigger and Modified Luteal Phase Adding a Bolus of GnRHa at the Time of Implantation: a RCT

    Not yet reported Centre Hospitalier Universitaire Ibn Rochd 328 participants Est. completion 2017-03 2 sites
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03169166

    The Use of GnRH Agonist Trigger for Final Follicle Maturation in Women Undergoing Assisted Reproductive Technologies

    Not yet reported American University of Beirut Medical Center 277 participants Est. completion 2021-10-01 1 site Stand-alone
    Other conditions: Sterility, Infertility
    View official trial listing →
  • Completed NCT NCT03447184

    Long-term Endogenous Androgen Priming in Bologna Criteria Poor Responder Patients - A Pilot Study

    Mỹ Đức Hospital 30 participants Est. completion 2019-03-01 1 site
    Other conditions: Poor Ovarian Response
    View official trial listing →
  • Completed NCT NCT03555942

    Luteal Phase-start Ovarian Stimulation With Corifollitropin Alfa

    Not yet reported Fundacion Dexeus 44 participants Est. completion 2021-12-01 2 sites Stand-alone
    Other conditions: Infertility
    View official trial listing →
  • Completed NCT NCT03557268

    Pubertal Blockade and Hormone Therapy in Transgender Youth

    University of Colorado, Denver 19 participants Est. completion 2020-09-09 1 site
    Other conditions: Gender Identity, Gender Dysphoria, Gender Identity Disorder in Adolescence and Adulthood
    View official trial listing →
  • Completed NCT NCT03745027

    Follicular Fluid Sialic Acid Levels in IVF Cycles

    Not yet reported Kanuni Sultan Suleyman Training and Research Hospital 87 participants Est. completion 2016-01-01 1 site Stand-alone
    Other conditions: in Vitro Fertilization
    View official trial listing →
  • Active, not recruiting NCT NCT03767244

    A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy

    Not yet reported Janssen Research & Development, LLC 2517 participants Est. completion 2028-10-13 203 sites Stand-alone
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Completed NCT NCT03825445

    GnRH Agonist Versus hCG Trigger in Ovulation Induction With Intrauterine Insemination.

    Not yet reported Hue University of Medicine and Pharmacy 197 participants Est. completion 2017-06-30 Stand-alone
    Other conditions: Ovulation Induction
    View official trial listing →
  • Status unknown NCT NCT03882190

    The Clinical Significance of Ovarian Function Detection and Protection in Fertility Preservation Surgery for Ovarian Malignancy

    Not yet reported Second Affiliated Hospital of Wenzhou Medical University 20 participants Est. completion 2021-04-01 Stand-alone
    Other conditions: Fertility Preservation Surgery, Ovarian Malignancy
    View official trial listing →
  • Status unknown NCT NCT03948828

    Clinical Study of NK Cells in the Treatment of Severe Endometriosis

    Not yet reported Shenzhen People's Hospital 60 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: NK Cell Mediated Immunity, Endometriosis
    View official trial listing →
  • Status unknown NCT NCT03954197

    Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients

    Not yet reported Hôpital Jean Verdier 204 participants Est. completion 2019-10-09 1 site
    Other conditions: Fertility Preservation, Breast Cancer
    View official trial listing →
  • Completed NCT NCT03965949

    Different Strategies in Frozen IVF/ICSI Cycles

    National and Kapodistrian University of Athens 311 participants Est. completion 2019-12-02 1 site
    Other conditions: Pregnancy Rates
    View official trial listing →
  • Status unknown NCT NCT04087408

    Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial

    Not yet reported Moustafa Mohammed Abouelea 150 participants Est. completion 2022-12-31 1 site
    Other conditions: Effect of Adding GnRHa as Luteal Phase Support in Antagonist ART Cycles
    View official trial listing →
  • Completed NCT NCT04108208

    A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)

    Not yet reported Janssen Research & Development, LLC 75 participants Est. completion 2026-06-05 27 sites Stand-alone
    Other conditions: Prostatic Neoplasms
    View official trial listing →
  • Status unknown NCT NCT04192812

    PREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERİN FIBROIDS

    Not yet reported Alkü Alanya Education and Research Hospital 100 participants Est. completion 2021-12-30 1 site Stand-alone
    Other conditions: Uterine Fibroid, Gonadotropin-Releasing Hormone-Dependent Precocious Puberty
    View official trial listing →
  • Completed NCT NCT04224818

    Dual Trigger in the Final Oocyte Maturation in Poor Ovarian Responders

    Not yet reported American University of Beirut Medical Center 140 participants Est. completion 2019-08-30 1 site Stand-alone
    Other conditions: Poor Ovarian Reserve
    View official trial listing →
  • Completed NCT NCT04500743

    Role of Suppression of Endometriosis With Progestins Before IVF-ET

    Not yet reported National Research Centre, Egypt 134 participants Est. completion 2020-04-30 1 site
    Other conditions: IVF, Endometriosis, Pregnancy Rate, Progestins, GnRH-analogue
    View official trial listing →
  • Status unknown NCT NCT04797338

    Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

    Not yet reported Assaf-Harofeh Medical Center 100 participants Est. completion 2021-09-30 1 site
    Other conditions: Pregnancy Early, Miscarriage, Ovarian Hyperstimulation Syndrome
    View official trial listing →
  • Withdrawn NCT NCT04850261

    Injection Free IVF

    Not yet reported Insel Gruppe AG, University Hospital Bern Est. completion 2024-03-31
    Other conditions: Fertility Disorders
    View official trial listing →
  • Completed NCT NCT05122377

    RWE About QOL and Compliance of Patients With OFS in China

    Fudan University 562 participants Est. completion 2025-05-01 1 site
    Other conditions: Breast Cancer, Quality of Life, Hormone Receptor-positive Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05151016

    Long-term Use of Mifepristone in the Treatment of Adenomyosis

    Not yet reported Women's Hospital School Of Medicine Zhejiang University 140 participants Est. completion 2023-12-31 1 site
    Other conditions: Adenomyosis, Mifepristone
    View official trial listing →
  • Completed NCT NCT05341128

    A Study of Medical Records From Children With Central Precocious Puberty (CPP) in China

    Takeda 1477 participants Est. completion 2025-08-27 5 sites
    Other conditions: Central Precocious Puberty
    View official trial listing →
  • Completed NCT NCT05567731

    Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve

    Not yet reported Tanta University 30 participants Est. completion 2023-12-01 1 site Stand-alone
    Other conditions: Intracytoplasmic Sperm Injection, GnRH Agonist, Infertility, Ovarian Reserve
    View official trial listing →
  • Status unknown NCT NCT05667428

    A Multicenter Open-label Clinical Study on the Prevention of Premature Ovarian Failure After HSCT

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 200 participants Est. completion 2025-10-31 1 site
    Other conditions: Hematopoietic Stem Cell Transplantation, Premature Ovarian Failure
    View official trial listing →
  • Status unknown NCT NCT05885776

    Preoperative Treatment of HR+/HER2+Breast Cancer With Pirotinib, Trastuzumab and AI Research

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 48 participants Est. completion 2025-09-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05898321

    To Prevent Type I-II Myoma After TCRM Recurrence by Gonadotropin-releasing Hormone (GnRH )Analogues or Mifepristone

    Not yet reported Women's Hospital School Of Medicine Zhejiang University 294 participants Est. completion 2025-12-30 1 site Stand-alone
    Other conditions: Submucous Leiomyoma of Uterus
    View official trial listing →
  • Completed NCT NCT05969834

    HCG Levels After Ovulation Triggering as Predictors of ICSI Outcome

    Mansoura University 100 participants Est. completion 2022-08-07 1 site
    Other conditions: Infertility
    View official trial listing →
  • Active, not recruiting NCT NCT06027541

    Young Patients With Early Breast Cancer

    Peking Union Medical College Hospital 1000 participants Est. completion 2028-02-01 1 site
    Other conditions: Breast Cancer Female
    View official trial listing →
  • Completed NCT NCT06106932

    GnRH-a on Angiogenesis of Endometriosis

    Not yet reported University of Patras 60 participants Est. completion 2023-01 2 sites
    Other conditions: Angiogenesis, Endometriosis
    View official trial listing →
  • Status unknown NCT NCT06134271

    Rezvilutamide Plus Abiraterone for Metastatic Hormone-sensitive Prostate Cancer

    Not yet reported Jianbin Bi 160 participants Est. completion 2026-04-30 Stand-alone
    Other conditions: Metastatic Hormone-Sensitive Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06390904

    GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients

    Not yet reported, Not yet reported Xiaojun Chen 29 participants Est. completion 2027-07-30 2 sites
    Other conditions: Atypical Endometrial Hyperplasia, Progesterone Resistance, Obesity
    View official trial listing →
  • Not yet recruiting NCT NCT06487143

    Efficacy, Metabolism and BMD of the 3-month TP Compared to the 1-month TP in ICPP

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 134 participants Est. completion 2026-12-30 1 site
    Other conditions: Central Precocious Puberty
    View official trial listing →
  • Status unknown NCT NCT06495515

    Efficacy and Safety of Dalpiciclib Plus Toremifene in the Treatment of Advanced First-line HR Positive and HER2 Negative Breast Cancer: a Multicenter, Single Arm, Exploratory Phase II Clinical Study

    Not yet reported Tianjin Medical University Cancer Institute and Hospital 36 participants Est. completion 2026-06-30 Stand-alone
    Other conditions: CANCER, BRAEST CANCER, Late Frontline
    View official trial listing →
  • Completed NCT NCT06581679

    Adenomyosis and Pregnancy: Levonorgestrel vs. GnRH for Blastocyst Transfer

    Not yet reported Zagazig University 184 participants Est. completion 2024-07-01 1 site
    Other conditions: Adenomyosis
    View official trial listing →
  • Not yet recruiting NCT NCT06768411

    The Dosage Exploration Study of PEG-rhGH for Treating Short Stature in Prepubertal and Pubertal Children

    Not yet reported Second Affiliated Hospital of Wenzhou Medical University 240 participants Est. completion 2027-06-01
    Other conditions: Short Stature
    View official trial listing →
  • Not yet recruiting NCT NCT06942377

    Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy

    Not yet reported Peking University People's Hospital 140 participants Est. completion 2027-12-01 1 site
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT07481942

    Body Composition Assessment in Transgender Population.

    Celia Bañuls 70 participants Est. completion 2025-10-31 1 site
    Other conditions: Transgender
    View official trial listing →
  • Not yet recruiting NCT NCT07527806

    Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

    Not yet reported Peking University Cancer Hospital & Institute 156 participants Est. completion 2029-12-31 Stand-alone
    Other conditions: Breast Cancer
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: GnRHa, Triprorelin acetate

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.